🏛️ Verified NIH Record • Updated 2020-10-21
Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers (NCT03154619)
Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers: a Two-arm, Double-blind, Placebo-controlled, Randomized Controlled Trial.
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: SerenaGroup, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The safety and efficacy of beta glucan products, and specifically TR 987, in the treatment of chronic venous insufficiency ulcers has been established. This study is designed to determine the most efficient method of treatment.
Who can join: Review the eligibility criteria below.
Location: New Hope Podiatry Clinic — Los Angeles, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- New Hope Podiatry Clinic — Los Angeles, California
- Barry University Clinical Research — North Miami Beach, Florida
- Royal Research Corp — Pembroke Pines, Florida
- Deborah Heart and Lung Center — Browns Mills, New Jersey
- Cleveland Foot and Ankle Clinic — Cleveland, Ohio
- The Foot and Ankle Wellness Center — Ford City, Pennsylvania
- Armstrong County Memorial Hospital — Kittanning, Pennsylvania
- SerenaGroup Research Institute — Pittsburgh, Pennsylvania
- Martin Foot and Ankle — York, Pennsylvania
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Venous Leg Ulcer
- Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III) — Hialeah, Florida
- LUT017 Gel for Venous Leg Ulcers and Chronic Non-Healing Skin Wounds in Adults — Los Angeles, California
- Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers. — Monroeville, Pennsylvania
- Tissue Repair Gel in Venous Leg Ulcers (US) — Tucson, Arizona
- Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers — Alexandria, Louisiana
Explore by condition: All Venous Leg Ulcer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.